AI Transparency Report
The Histochemical Society Inc. demonstrates a generally stable financial position with assets consistently exceeding liabilities, indicating good fiscal management. Over the past few years, the organization has experienced fluctuations in revenue and expenses, with the latest period (202312) showing expenses exceeding revenue by $67,445 ($495,248 vs $427,803). This trend of expenses outpacing revenue was also observed in 202212, where expenses were $674,581 against revenues of $365,705. Despite these operational deficits in recent years, the organization maintains a healthy asset base of $4,463,587 in 202312, suggesting strong reserves built from prior profitable years, such as 202112 where revenue significantly exceeded expenses ($551,062 vs $399,226).
The organization's transparency is commendable, particularly with 0% officer compensation reported across all available filings. This indicates that the leadership is likely volunteer-based or compensated through other means not classified as officer compensation, which can be a positive sign for donor confidence. The consistent filing of IRS Form 990s over 13 periods further reinforces their commitment to public accountability. While recent operational deficits warrant monitoring, the overall financial health appears robust due to substantial assets and minimal liabilities, ensuring the organization's long-term viability.